Life Science

A latanoprost-related isomer containing both a double bond at C-13,14 and an invered (b) hydroxyl group at C-15 a potential impurity in most commercial preparations of the lantanoprost bulk drug product.

A latanoprost-related isomer containing both a double bond at C-13,14 and an invered (b) hydroxyl group at C-15 a potential impurity in most commercial preparations of the lantanoprost bulk drug product.

A latanoprost-related isomer containing both a double bond at C-13,14 and an invered (b) hydroxyl group at C-15 a potential impurity in most commercial preparations of the lantanoprost bulk drug product.

A latanoprost-related isomer containing both a double bond at C-13,14 and an invered (b) hydroxyl group at C-15 a potential impurity in most commercial preparations of the lantanoprost bulk drug product.

An isomer of 17-phenyl trinor PGF2&alpha, characterized by an inverted (&beta) hydroxyl group at C-15.

An isomer of 17-phenyl trinor PGF2&alpha, characterized by an inverted (&beta) hydroxyl group at C-15.

An isomer of 17-phenyl trinor PGF2&alpha, characterized by an inverted (&beta) hydroxyl group at C-15.

15(R)-HEDE is isolated by the chromatographic resolution of (&plusmn)15-HEDE. There are no reports of biological activity associated with 15(R)-HEDE in the literature.

15(R)-HEDE is isolated by the chromatographic resolution of (&plusmn)15-HEDE. There are no reports of biological activity associated with 15(R)-HEDE in the literature.

15(R)-HEDE is isolated by the chromatographic resolution of (&plusmn)15-HEDE. There are no reports of biological activity associated with 15(R)-HEDE in the literature.

15(R)-HEDE is isolated by the chromatographic resolution of (&plusmn)15-HEDE. There are no reports of biological activity associated with 15(R)-HEDE in the literature.

15(R)-HETE is produced when aspirin-inhibited COX-2 is incubated with arachidonic acid. The clinical significance of 15(R)-HETE and its potential downstream metabolites is the subject of current investigations.